Extension to deadline under Rule 2.6(c)

On 24 January 2026, the Company announced that each of Bridgepoint Advisers Limited ("Bridgepoint") and Triton Investment Advisers LLP ("Triton") are amongst the parties in discussions with the Company in the context of the strategic review announced on 18 September 2025.

The announcement stated that, in accordance with Rule 2.6(a) of the Code, Bridgepoint and Triton are each required, by not later than 5.00 p.m. (London time) on 21 February 2026 (the "PUSU Deadline"), to do one of the following: (i) announce a firm intention to make an offer for the Company in accordance with Rule 2.7 of the Code; or (ii) announce that they do not intend to make an offer for the Company, in which case the announcement will be treated as a statement to which Rule 2.8 of the Code applies.

Discussions between the Company and each of Bridgepoint and Triton are ongoing and, to allow further time for these discussions to continue to take place, the Board of Spire Healthcare has requested, and the Panel on Takeovers and Mergers (the "Takeover Panel") has consented to, an extension to the PUSU Deadline.

Consequently, in accordance with Rule 2.6(a) of the Code, Bridgepoint and Triton are required, by not later than 5.00pm on 21 March 2026, either to announce a firm intention to make an offer in accordance with Rule 2.7 of the Code or to announce that they do not intend to make an offer, in which case the announcement will be treated as a statement to which Rule 2.8 of the Code applies. This deadline may be further extended by the Company with the consent of the Takeover Panel, in accordance with Rule 2.6(c) of the Code.

This announcement is not an announcement of a firm intention to make an offer under Rule 2.7 of the Code and there can be no certainty that any firm offer will be made nor as to the terms on which any offer will be made. Further announcements will be made in due course as appropriate.

Notice related to financial advisers

Rule 26.1 disclosure

Additional Information